Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Kuibyshevazot bought out Tecnimont's stake in JV Volgafert

12/4/24 KAZT

Moscow Exchange summarized the results of trading in November

12/3/24 MOEX

MGKL acquired 26 pawnshops and commission stores

12/3/24 MGKL

Softline will merge three subsidiaries into a subholding

12/3/24 SOFL

VTB is ready to stop retail unsecured lending

12/3/24 VTBR

Yandex Go expands geographical presence in Uzbekistan

12/3/24 YDEX

Yandex bought the technology platform Pruffme

12/3/24 YDEX

Shareholders of Polyus approved dividends

12/2/24 PLZL

Alfa Bank wants to recover $77.3 mln from Nornickel

12/2/24 GMKN

Rosdorbank to place 3.6 million shares of additional share issue

12/2/24 RDRB